Unilever to buy men’s grooming brand Dr. Squatch
Acquisition expands Unilever’s premium personal care portfolio and accelerates global push into men’s grooming.
Acquisition expands Unilever’s premium personal care portfolio and accelerates global push into men’s grooming.
Once complete, the combined company will operate as a private entity under the C&S banner, taking SpartanNash off public markets.
The suit invokes the Supreme Court’s 2024 Loper Bright Enterprises v. Raimondo decision as the basis for challenging the FTC’s enforcement powers.
Research reveals diet deficiencies and potential health risks for patients using popular weight loss drugs.
The new product enables consumers to browse and purchase directly within an ad unit, without ever leaving the content they’re viewing.
The platform includes a product comparison tool, score breakdowns, and transparency about independent testing by Canomiks.
Woman-owned brand brings clinically proven, clean wound care to a wider audience.
NACDS’ call to action comes amid ongoing efforts by the HHS to modernize the U.S. healthcare technology ecosystem.
The brand’s latest offerings feature clinically studied ingredients and are formulated to meet the evolving needs of consumers, especially women, at all life stages.
“These solutions bridge the gaps, providing insights that are not only granular but also actionable.”
Replacing the longstanding Reverse Logistics Association Conference & Expo, the inaugural NRF Rev will debut January 11–12, 2026, at the Sheraton New York Times Square Hotel.
This program enables eligible health plan members to enjoy personalized health and benefit plan offerings.
The legislation would require full transparency from PBMs, including the complete pass-through of ingredient costs and pharmacy dispensing fees.
The findings align closely with last week’s CNBC/NRF Retail Monitor, powered by Affinity Solutions.
“I am honored to take on the role of CEO at such a pivotal time in our company’s journey,” said Sevek.
PCMA hailed the measure as a critical step toward fostering greater market competition and reducing drug costs.